Fifth Third Bancorp $500 million inaugural sustainable notes offering
The company offered fixed-rate/floating-rate senior notes due 2027
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
SOPHiA GENETICS $234 million IPO and $20 million private placement
We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
Nubank $750 million Series G-1 financing
We advised Nubank on its Series G-1 financing
Disruptive Acquisition Corporation I $250 million IPO
We advised Disruptive Acquisition Corporation I, a SPAC, on its IPO and Nasdaq listing
Itiquira Acquisition $230 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Rotor Acquisition $276 million IPO
We advised the underwriter on the SPAC IPO and NYSE listing
Peabody Energy transaction support agreement and out-of-court notes exchange
Davis Polk is advising an ad hoc group of noteholders holding approximately 65% of Peabody Energy’s outstanding 6.000% senior secured notes due 2022, in connection with a notes amendment…
Marquee Raine Acquisition $373.75 million IPO
Davis Polk advised the sole underwriter in connection with the initial public offering of 37,375,000 units of Marquee Raine Acquisition Corp., including 4,875,000 units purchased pursuant…
Foley Trasimene Acquisition Corp. II $1.3 billion IPO
Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 130,000,000 units of Foley Trasimene Acquisition Corp. II for…
BioXcel Therapeutics $200 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…